CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Unichem Pharmaceuticals USA Inc. recalls Bisoprolol Fumarate and…

Unichem Pharmaceuticals USA Inc. recalls Bisoprolol Fumarate and Hydrochlorothiazide tablets

Read the official FDA notice

Published
11 Feb 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

CGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Brand / company
Unichem Pharmaceuticals USA Inc.
Codes / lots
Lot # GBHL24005A, Exp Date: 09/2026
Distribution
US Nationwide and PR.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.